Mesoblast

Biotherapeutics derived from proprietary adult stem cell-based technologies

placeMelbourne, Victoria, Australia calendar_todayFounded 2004 groups83 employees language mesoblast.com

Registered entities

Innovation

37 patent families (31 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 4,156 times.

YearFilings
201516
201621
201716
201817
201917
202013
202111
20225
20236
20247
20259
20262

Social engagement

Social engagement: 12.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital222%
Private equity111%
Bank & private debt222%
Other / undisclosed444%

Recent activity

1 Jun 2026
Event
ASX CEO Connect
27 May 2026
Event
ASX CEO Connect
30 Apr 2026
Milestone
revenue
Coming soon